Abalos Therapeutics raised $13.2M Series A venture round, led by Boehringer Ingelheim.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Private | — |
| Government Office | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$49.2M
Top Valuation
-
Abalos Therapeutics raised $13.2M in a Series A round.
The round was announced on 10/15/19.
The round was led by Boehringer Ingelheim, Dr. Aristotelis Nastos.